The U.S. food and drug administration: Drug information resource for formulary recommendations

Journal of Managed Care Pharmacy

Volumn 18, Issue 9 A, 2012, Pages 713-718

  Marchand, Heidi C ^a   Rose, Brenda J ^a   Fine, Anna M ^a   Kremzner, Mary E ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; GEFITINIB; ORPHAN DRUG;

ARTICLE; BREAST CANCER; CLINICAL TRIAL (TOPIC); DECISION MAKING; DRUG APPROVAL; DRUG FORMULARY; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HUMAN; LUNG CANCER; MANAGED CARE; PHARMACIST; POSTMARKETING SURVEILLANCE; RISK ASSESSMENT; DRUG DATABASE; HEALTH INSURANCE; INTERNET; ORGANIZATION AND MANAGEMENT; PHARMACY; PUBLICATION; UNITED STATES;

DATABASES, PHARMACEUTICAL; DRUG APPROVAL; FORMULARIES AS TOPIC; INTERNET; MANAGED CARE PROGRAMS; PHARMACEUTICAL SERVICES; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84872448188     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2012.18.9.713     Document Type: Article

References (1)

1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonized tripartite guideline: general considerations for clinical trials E8. Current Step 4 Version. July 17, 1997. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E8/Step4/E8_Guideline.pdf. Accessed November 29, 2012.